1,134
Participants
Start Date
April 20, 2022
Primary Completion Date
October 5, 2022
Study Completion Date
October 5, 2022
BNT162b2
Intramuscular injection
Placebo
Saline intramuscular injection
Seasonal Inactivated Influenza Vaccine
SIIV intramuscular injection
New Zealand Clinical Research (Auckland), Grafton
Optimal Clinical Trials, Grafton
Aotearoa Clinical Trials, Auckland
Middlemore Clinical Trials, Auckland
Northern Beaches Clinical Research, Brookvale
Westmead Hospital, Westmead
Pacific Clinical Research Network - Rotorua, Rotorua
P3 Research - Tauranga, Tauranga
Lakeland Clinical Trials Culloden, Papamoa Beach
Emeritus Research, Camberwell
Lakeland Clinical Trials Waikato, Hamilton
Barwon Health, Geelong
Paratus Clinical Research Brisbane, Albion
AusTrials - Wellers Hill, Wellers Hill
P3 Research - Hawke's Bay, Havelock North
P3 Research - Palmerston North, Palmerston North
Lakeland Clinical Trials Wellington, Ebdentown. Upper Hutt
P3 Research - Kapiti, Paraparaumu
Capital, Coast and Hutt Valley District - Wellington Regional Hospital, Wellington
P3 Research - Wellington, Wellington
Southern Clinical Trials Tasman, Nelson
New Zealand Clinical Research (Christchurch), Christchurch
Pacific Clinical Research Network - Forte, Christchurch
Australian Clinical Research Network, Sydney
Southern Clinical Trials Totara, New Lynn
Southern Clinical Trials Waitemata Ltd, Auckland
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
BioNTech SE
INDUSTRY